Biovail recovers from Tuesday selloff

Article Abstract:

San Diego, Calif.-based DJ Pharma Inc. will be acquired by Mississauga, Ont.-based Biovail Corp. for $162.5 million. Biovail may introduce its generic version of the heart drug Tiazac in 2002.

Product introduction, DJ Pharma Inc.

---

Biovail buys rights to leading heart drug

Article Abstract:

Biovail Corp. has acquired the North American rights to the heart medication, Cardizem for $409.5 million (U.S.). The rights were bought from the French pharmaceutical giant, Aventis S.A.

Contracts, Aventis S.A., Biovail Corporation International, Cardizem (Medication)

---

Biovail shares hit 52-week high (Biovail Corp., reports strong earnings)

Article Abstract:

Mississauga-based pharmaceuticals firm Biovail Corp., reports strong earnings for the year 2000, with revenue expected to be between $540 and $570 million, compared to last year's $309.2 million. Biovail's stock closed at $71.55, the highest for the year.

Sales, profits & dividends, Market information - general, Securities prices, Pharmaceutical Preparations, Finance

Similar abstracts:

• Abstracts: Magazines closely weigh ad rates for the fourth quarter and early 2002 in a moribund market. Forbes and Fortune are trying to bolster circulation among business movers and shakers
• Abstracts: Coke hopes nostalgia sells with holiday advertising campaign. Coke to target lige stages, styles in new ads
• Abstracts: For first time, Coke puts kids of color on collectible cans. Reinemund faces Pepsi challenge
• Abstracts: Car rental companies unload part of fleets as business falls. Business travel falls as airfares climb, earnings drop
• Abstracts: Canadian Standard Life policy holders could reap huge windfall. Big top gets bigger for Cirque du Soleil

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.